Intuitive Surgical, Inc. (NASDAQ:ISRG) Shares Sold by James Hambro & Partners LLP

James Hambro & Partners LLP trimmed its stake in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG) by 7.6% in the 1st quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 224,066 shares of the medical equipment provider’s stock after selling 18,556 shares during the quarter. Intuitive Surgical accounts for 4.6% of James Hambro & Partners LLP’s holdings, making the stock its 13th largest holding. James Hambro & Partners LLP owned about 0.06% of Intuitive Surgical worth $110,957,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Several other institutional investors and hedge funds have also recently bought and sold shares of ISRG. Exchange Traded Concepts LLC lifted its holdings in Intuitive Surgical by 5.5% during the 1st quarter. Exchange Traded Concepts LLC now owns 42,891 shares of the medical equipment provider’s stock worth $21,243,000 after buying an additional 2,225 shares during the last quarter. Pinion Investment Advisors LLC acquired a new position in Intuitive Surgical in the 1st quarter valued at about $787,000. Cornell Pochily Investment Advisors Inc. increased its position in Intuitive Surgical by 2.1% in the 1st quarter. Cornell Pochily Investment Advisors Inc. now owns 1,189 shares of the medical equipment provider’s stock valued at $589,000 after acquiring an additional 24 shares during the period. Aries Wealth Management acquired a new position in Intuitive Surgical in the 1st quarter valued at about $263,000. Finally, Ritholtz Wealth Management increased its position in Intuitive Surgical by 6.1% in the 1st quarter. Ritholtz Wealth Management now owns 4,738 shares of the medical equipment provider’s stock valued at $2,347,000 after acquiring an additional 273 shares during the period. 83.64% of the stock is owned by institutional investors and hedge funds.

Wall Street Analysts Forecast Growth

Several research firms have issued reports on ISRG. Evercore ISI dropped their target price on Intuitive Surgical from $510.00 to $470.00 and set an “in-line” rating on the stock in a research report on Wednesday, April 23rd. Deutsche Bank Aktiengesellschaft lowered Intuitive Surgical from a “hold” rating to a “sell” rating and reduced their target price for the company from $515.00 to $440.00 in a research note on Monday, June 9th. Truist Financial reduced their target price on Intuitive Surgical from $605.00 to $590.00 and set a “buy” rating on the stock in a research note on Wednesday, April 23rd. BTIG Research set a $560.00 price target on Intuitive Surgical and gave the stock a “buy” rating in a research note on Monday, April 14th. Finally, Robert W. Baird cut their target price on Intuitive Surgical from $600.00 to $575.00 and set an “outperform” rating on the stock in a research report on Wednesday, April 23rd. One investment analyst has rated the stock with a sell rating, four have given a hold rating and fifteen have issued a buy rating to the company’s stock. According to data from MarketBeat, the stock currently has a consensus rating of “Moderate Buy” and an average price target of $588.95.

Intuitive Surgical Stock Performance

Shares of NASDAQ:ISRG opened at $512.18 on Friday. Intuitive Surgical, Inc. has a 52 week low of $413.82 and a 52 week high of $616.00. The company has a market capitalization of $183.57 billion, a PE ratio of 79.90, a PEG ratio of 5.85 and a beta of 1.67. The company has a 50 day moving average price of $526.57 and a two-hundred day moving average price of $538.46.

Intuitive Surgical (NASDAQ:ISRG) last issued its earnings results on Tuesday, April 22nd. The medical equipment provider reported $1.81 EPS for the quarter, beating the consensus estimate of $1.71 by $0.10. Intuitive Surgical had a net margin of 27.81% and a return on equity of 14.55%. The firm had revenue of $2.25 billion during the quarter, compared to the consensus estimate of $2.19 billion. During the same quarter in the prior year, the firm earned $1.50 earnings per share. On average, sell-side analysts forecast that Intuitive Surgical, Inc. will post 6.43 earnings per share for the current year.

Insider Transactions at Intuitive Surgical

In other Intuitive Surgical news, EVP Gary Loeb sold 1,700 shares of the stock in a transaction on Friday, April 25th. The shares were sold at an average price of $513.18, for a total value of $872,406.00. Following the completion of the sale, the executive vice president now owns 2,245 shares in the company, valued at $1,152,089.10. This trade represents a 43.09% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which is available through this link. Also, EVP Robert Desantis sold 188 shares of the stock in a transaction on Monday, April 28th. The shares were sold at an average price of $515.91, for a total transaction of $96,991.08. Following the completion of the sale, the executive vice president now owns 5,224 shares of the company’s stock, valued at approximately $2,695,113.84. This represents a 3.47% decrease in their position. The disclosure for this sale can be found here. Insiders sold 4,998 shares of company stock valued at $2,611,577 over the last quarter. Corporate insiders own 0.70% of the company’s stock.

Intuitive Surgical Company Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.